A case study on Claritas Rx’s Ascend® Platform offers a compelling look at how technology-driven intervention strategies can drive better outcomes for liver disease patients. A mid-sized U.S. pharmaceutical company partnered with Claritas Rx to tackle persistent challenges in patient conversions and medication adherence—key hurdles often exacerbated by lengthy prescription processing times and medication stock-outs.
Addressing Key Challenges
The pharmaceutical company was struggling to:
- Manage patients affected by long waiting periods before their first prescription fill.
- Improve refill rates and patient retention, particularly for those experiencing stock-outs and prolonged waits.
- Quantify the full impact of intervention strategies to allocate resources effectively and improve patient outcomes.
Impactful Results
Leveraging the Claritas Rx Ascend Platform, the client’s patient services team took an active approach:
- Averaged 10,000 patient interventions every quarter.
- Delivered fast support, with an average response time of less than two days.
- For patients waiting 31 or more days for their first fill, intervention boosted the fill rate by 6 percentage points.
- Patients who experienced out-of-stock situations for over 51 days saw a 23 percentage point increase in refill rates following engagement.
Perhaps most telling, these targeted interventions resulted in 784 additional patient months for newly enrolled and shipped patients.
Why It Matters
This case study demonstrates the value of real-time, data-driven patient support. By quickly identifying stalled prescriptions and responding proactively, the Ascend Platform helped patients get critical medications faster and supported them through refill. The measurable improvements—both in speed of service and patient adherence—highlight the growing role of digital solutions in specialty pharmaceutical care.
Patient services in the specialty pharmaceutical sector that seek meaningful gains in conversion rates, adherence, and patient care outcomes can look to the Claritas Rx Ascend Platform as a proven model for success.
Source: Claritas Rx, data on file, August 2025. Case study based on a mid-sized pharmaceutical company in the liver disease specialty.